Lippman Evan 4
4 · TEVA PHARMACEUTICAL INDUSTRIES LTD · Filed May 19, 2025
Insider Transaction Report
Form 4
Lippman Evan
EVP, Business Development
Transactions
- Award
Restricted Share Units
2025-05-14+148,016→ 148,016 total→ Ordinary Shares (148,016 underlying) - Award
Restricted Share Units
2025-05-14+47,365→ 47,365 total→ Ordinary Shares (47,365 underlying)
Footnotes (4)
- [F1]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F2]Restricted share units were granted on May 14, 2025 with 11,841 vesting on each of May 14, 2026, May 14, 2027 and May 14, 2028, and 11,842 vesting on May 14, 2029.
- [F3]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F4]Restricted share units were granted on May 14, 2025 with 74,008 vesting on May 14, 2026, and 37,004 vesting on each of May 14, 2027 and May 14, 2028.